Grazoprevir (MK-5172) Administered With Peginterferon and Ribavirin in Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-003)
Clinical trial NCT01353911 · COMPLETED
Trial details
- NCT number
- NCT01353911
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-27
- Primary completion
- 2013-01-20
- Enrollment
- 368
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.